p53-independent activities of MDM2 and their relevance to cancer therapy

Zhuo Zhang1, Ruiwen Zhang

  • 1Department of Pharmacology and Toxicology, Division of Clinical Pharmacology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Current Cancer Drug Targets
|February 22, 2005
PubMed

Insights

The MDM2 protein regulates itself via p53, but also performs crucial functions independently of p53. Targeting these p53-independent MDM2 activities offers a promising new strategy for cancer therapy.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • The feedback loop between p53 and MDM2 is a critical regulator of cellular processes.
  • MDM2 is known to negatively regulate p53, forming an auto-regulatory loop.
  • Emerging evidence suggests MDM2 possesses functions independent of p53.

Purpose of the Study:

  • To review the p53-independent activities of MDM2.
  • To explore MDM2's interactions with other cellular proteins.
  • To provide a basis for developing novel MDM2-targeted cancer therapies.

Main Methods:

  • Literature review of studies on MDM2.
  • Analysis of MDM2's roles in various cellular processes.
  • Examination of MDM2's oncogenic activities independent of p53.

Main Results:

  • MDM2 exhibits p53-independent roles in cell cycle control, differentiation, DNA repair, and more.
  • MDM2 possesses oncogenic transformational activities independent of p53.
  • Anti-MDM2 therapies show efficacy regardless of p53 status.

Conclusions:

  • MDM2 has significant biological functions and oncogenic potential independent of p53.
  • Understanding these p53-independent activities is key to developing new cancer treatments.
  • Targeting MDM2 offers a therapeutic avenue for various human malignancies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...